Rheumatoid Arthritis News

Patients with atherosclerosis and elevated LDL plus autoimmune or inflammatory disease may derive particular CV benefit from PCSK9 inhibition with evolocumab, a speaker reported.

In this video, Maria Danila, MD, discusses exciting new research in the field of rheumatoid arthritis.

In this video, Maria Danila, MD, discusses how dietary changes can impact rheumatoid arthritis.

In this video, Maria Danila, MD, discusses challenges in the management of rheumatoid arthritis.

In this video, Maria Danila, MD, discusses recent advancements in rheumatoid arthritis.

Simlandi injection, an interchangeable biosimilar to Humira, is now available in the U.S. for the treatment of psoriatic arthritis, plaque psoriasis and other conditions, Teva Pharmaceuticals and Alvotech announced in a press release.

Physician understanding about the safety and efficacy of Janus kinase inhibitors for patients with rheumatoid arthritis has evolved with real-world and clinical trial data.

Boehringer Ingelheim has partnered with Quallent Pharmaceuticals to expand access to its Humira biosimilar citrate-free adalimumab-adbm in the United States, according to a company press release.

Last year, a presentation at the American College of Rheumatology Convergence provided a glimpse into a potential mechanism of inflammation in rheumatoid arthritis that may fundamentally alter treatment approaches.

DESTIN, Fla. — Ongoing, frank discussions about reproductive health with patients of childbearing age is critical to safe pregnancy outcomes, according to a presenter at the Congress of Clinical Rheumatology East.